Article Per Year (5 Year)
p-Index From 2021 - 2026
2.024
P-Index
This Author published in this journals
All Journal AGRIVITA, Journal of Agricultural Science Seminar Nasional Lahan Suboptimal PUBLIKASI PENELITIAN TERAPAN DAN KEBIJAKAN Jurnal Peduli Masyarakat Jurnal Kesehatan STIKes IMC Bintaro Narra J International Journal of Management, Entrepreneurship, Social Science and Humanities (IJMESH) Jurnal Kesehatan EDUCATIONE: Journal of Education Research and Review
Oom Komalasari
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Decision Sciences, Operations Research & Management Dentistry Economics, Econometrics & Finance Education Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Nursing Public Health Social Sciences Other

Published : 21 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 21 Documents
Search

 1   2   3 
Comparison of anti-SARS-CoV-2 IgG seropositivity among vaccinated, unvaccinated, and COVID-19 survivor individuals: A cross-sectional study in Palembang, Indonesia Retnaningsih, Ekowati; Nuryanto, Nuryanto; Oktarina, Reni; Komalasari, Oom; Maryani, Sri; Larasti, Veny; Fertilita, Soilia
Narra J Vol. 5 No. 3 (2025): December 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v5i3.2890

Abstract

Measurement of anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody levels provides evidence of prior infection or vaccination. Persistent vaccine hesitancy underscores the importance of robust, evidence-based data to inform policy decisions. The aim of this study was to compare anti-SARS-CoV-2 IgG seropositivity among vaccinated individuals, unvaccinated individuals, and coronavirus disease 2019 (COVID-19) survivors in the community during the pandemic. In this cross-sectional study, 517 participants were enrolled, including 167 vaccinated individuals, 97 COVID-19 survivors, and 253 unvaccinated individuals, selected through multistage cluster sampling of 40 clusters. Anti-SARS-CoV-2 IgG seropositivity was defined as ≥50 AU/mL. Multivariable logistic regression was performed to evaluate associations between group type and seropositivity, adjusting for demographic factors, COVID-19 symptoms, hypertension, and body mass index (BMI). Vaccinated individuals demonstrated significantly higher odds of seropositivity compared with unvaccinated participants (odds ratio (OR)=5.60; 95% confidence interval (CI): 2.36–13.27). Covariates independently associated with seropositivity (p<0.05) included the presence of COVID-19 symptoms, hypertension, and BMI. Vaccination was strongly associated with increased anti-SARS-CoV-2 IgG seropositivity in the community, independent of clinical and demographic factors. These findings support ongoing vaccination campaigns and highlight the relevance of comorbidities and symptomatic history in shaping humoral immune responses.
Co-Authors Adelia Yasinta, Alvira Aidah, Nurul Amelia Putri, Ristina Ayu Sri Saraswati, Dewa Azis, Fareza Putri Budi Febriyanto Defriyanti, Wenni Tania DEWI ANGGRAINI Efriandi, Efriandi Ekowati Retnaningsih Fauziah Koes Fertilita, Soilia Irwan Irwan Juairiyah, Oktaf Larasti, Veny Lubis, Vebry Haryati Maryani, Sri Nur Fitra Sintya Rukmana, Nisa Nuryanto Nuryanto Pasaribu, Sondang Deri Maulina Raden Mohamad Herdian Bhakti Rahayu, Niken Probowati Nur Ramlah Arief Ramlah Arief Reni Oktarina Rohmah, Asyifa Nur Sihombing, Putriatdah Sarinah Sri Maryani suheti Suheti, Suheti Suroso Suroso Suswara, Tri Novayanti Sylvani, Sylvani Tantri Wenny Sitanggang Tri Susanto Wardojo, Moelyono Moekti Widhawati, Riswahyuni Wiwi Hartati Wiwi Marwiyah Yenny Sugiarti Yoppi Iskandar Yuyun Dwi Haryanti